Research into the prevention, early detection, and treatment of small cell lung cancer (SCLC) is being done in many medical centers throughout the world. Prevention Tobacco Prevention offers the greatest opportunity to fight lung cancer. Although decades have passed since … Continued
A study presented at the American Association for Cancer Research Annual Meeting by the University of Colorado Cancer Center describes the ways that cancer cells have evolved to resist the drug LOXO-101, currently being evaluated in phase I and II … Continued
Researchers from the Medical University of Vienna have found a possible clue regarding mesothelioma’s resistance to chemotherapy. They believe that cancer cells break away during normal chemotherapy, circulate throughout the body, and then rejoin together into “cancer clusters” that drugs … Continued
Ariad Pharmaceuticals (based in Cambridge, MA and Lausanne, Switzerland) updated results for brigatinib, a small-molecule drug that targets a specific gene in a range of cancers, including non-small cell lung cancer. The survival rate of patients in the trials has … Continued
The opportunity to detect the cancer early means more individuals can be cured with surgical excision or with radiation therapy. Either can be followed by adjuvant chemotherapy for those with a high likelihood of microscopic disease spread. Radiation therapy is … Continued
